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Abstract
The blood-brain barrier (BBB) maintains brain homeostasis and limits the entry of toxins and pathogens into the brain.
Despite its importance, little is known about the molecular mechanisms regulating the development and function of this
crucial barrier. In this study we have developed methods to highly purify and gene profile endothelial cells from different
tissues, and by comparing the transcriptional profile of brain endothelial cells with those purified from the liver and lung, we
have generated a comprehensive resource of transcripts that are enriched in the BBB forming endothelial cells of the brain.
Through this comparison we have identified novel tight junction proteins, transporters, metabolic enzymes, signaling
components, and unknown transcripts whose expression is enriched in central nervous system (CNS) endothelial cells. This
analysis has identified that RXRalpha signaling cascade is specifically enriched at the BBB, implicating this pathway in
regulating this vital barrier. This dataset provides a resource for understanding CNS endothelial cells and their interaction
with neural and hematogenous cells.
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Introduction
The vasculature of the CNS forms an endothelial barrier, not
found in other tissues, that limits the flow of molecules and ions
between the blood and the brain. This BBB is crucial for
maintaining brain homeostasis and for limiting the penetration of
toxins and pathogens into the brain [1]. The importance of the
BBB is highlighted by the severe pathology of diseases in which it is
disrupted, including stroke, edema, brain traumas and multiple
sclerosis [2]. The BBB also poses an obstacle for the treatment of
neurological disorders as it can greatly limit drug delivery into the
brain [3].
Many of the properties of the BBB are manifested in the
endothelial cells which make up the walls of the blood vessels.
Endothelial cells in the brain differ from endothelial cells in other
tissues in that they are held together by high electrical resistance
tight junctions and contain few transcytotic vesicles, limiting the
paracellular and transcellular flow of molecules from the blood
into the brain [4]. In addition, CNS endothelial cells express a
variety of transporters, both to provide the CNS with specific
nutrients, and also to efflux potential toxins from the CNS.
Whereas the endothelial cells form the barrier, transplantation
studies have demonstrated that these properties are not intrinsic to
the endothelial cells but signaled by the brain microenvironment
[5]. Evidence suggests that the BBB is induced and regulated by its
close association with astrocytes, pericytes and other neural cells,
however the molecular nature of these interactions remains a
mystery [6,7,8].
Several studies have taken different approaches to understand
the genomics of the BBB, including microarray analysis,
subtractive hybridization and serial analysis of gene expression
[9,10,11]. These studies have provided information about the gene
expression of CNS vessels but had two limitations. First, because
these studies used whole vessel fractions, which contain many
different cell types, the transcriptomes of the individual cellular
components, the endothelial cells and the pericytes, are not yet
known. Second, these studies compared the gene expression of
brain vessels with whole tissue fractions instead of purified
peripheral vessels. Paramount to understanding the function of
the BBB is a comparison of purified endothelial cells from brain
with purified endothelial cells from peripheral tissues.
Here we utilize fluorescence-activated cell sorting (FACS) to
highly purify endothelial cells from the brain, liver and lung of
Tie2GFP transgenic mice [12]. Using Affymetrix microarrays to
gene profile these purified cell populations, we have identified a set
of genes whose expression is highly enriched at the BBB. These
genes include tight junction molecules, transporters, signaling
molecules, and other molecule classes. This analysis has implicated
Wnt and RXRalpha signaling cascades in regulating this crucial
barrier.
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Ethics Statement
All experiments were approved by Stanford University IACUC
committee, approved protocol #10726.
FACS purification of GFP
+ cells
Homozygous Tie2GFP mice (strain 003658) were obtained
from Jackson labs and bred to maintain homozygosity. Cell
suspensions were prepared from cerebral cortex, liver or lung
based on procedures previously described [13,14]. For brain
samples, the cerebral cortex was dissected away from the
forebrain, then the meninges were peeled off with fine forceps.
For liver samples, peripheral regions of each lobe were utilized to
avoid the hepatic portal vein ensuring the tissue vasculature
consisted primarily of capillaries. Whole lung lobes were utilized.
Each tissue was diced with a scalpel, and enzymatically dissociated
with a papain solution (40 U/ml Worthington-3126) containing L-
cysteine (0.4 mg/ml, Sigma C 7477) and DNase (125 U/ml,
Worthington LS002007) for 1.5 hours at 35uC, prior to mechan-
ical trituration in a solution containing ovomucoid (2 mg/ml,
Roche 109878), DNase (125 U/ml) and BSA (1 mg/ml, Sigma
A8806), to yield a cell suspension, which was recovered by
centrifugation. Cell suspensions were re-suspended in FACS buffer
(DPBS, 0.02%BSA with propidium iodide), and endothelial cells
were FACS purified based on GFP fluorescence utilizing a FACS
Vantage SE sorter (Becton Dickinson) and CellQuest software. For
each tissue, background GFP fluorescence was determined by
FACS analysis of cell suspensions from wild type FvB mice
(Charles River), and dead cells were eliminated by high propidium
iodide fluorescence. Forward scatter and side scatter analysis were
also used as gates to limit the sorting to single live cells. For
additional pericyte/VSM depletion, cell suspensions were stained
with a goat anti-mouse PDGFRbeta primary antibody (R & D
systems), and a donkey anti-goat secondary antibody labeled with
APC. For these experiments, background APC fluorescence was
gated with cell suspensions incubated with secondary, but not
primary antibody. In each case, two rounds of sorting were
performed for maximal purity, based on reanalysis. Cortical GFP
2
cells were isolated from Tie2GFP
+ mice with gating based on
background GFP fluorescence from wild type FvB mice.
GeneChip Analysis
Purification of RNA, generation of biotinylated cRNA, subse-
quent hybridization to Affymetrix Mouse Genome 430 2.0 Arrays
and raw image analysis with Affymetrix GCOS 1.3 software was
performed as previously described [14]. Three biological replicates
were used for each analysis of adult cells, whereas five biological
replicates were utilized for postnatal samples. Each biological
replicate represents a purification from different mice performed on
different days. The Significance Analysis of Microarrays (SAM)
methodwasused todetermine genesthat were significantlydifferent
between cell populations. For this analysis, samples were grouped
into 6 groups: brain parenchyma (GFP
2), brain vascular (GFP
+),
brain endothelial (GFP
+PDGFRbeta
2), postnatal brain GFP
+, liver
endothelial and lung endothelial. Probe sets were included in this
statistical analysis if they were defined as being called present and
having anintensitylevelgreaterthan 200 inat leasttwo-thirds ofthe
samples in at least one group. The significance thresholds were set
for a false discovery rate of less than 1% with a fold-change of
greater than 2.06. For each data analysis presented in this paper,
fold-enrichment was calculated as expression value of one data set
divided by the second. In each table presented, probe sets were
included only if gene expression was $200 in the enriched data set.
In comparisons of brain endothelial to lung and liver endothelial
samples, orcomparisonsofadult and postnatalbrainsamples,GFP
+
samples for each tissue were compared, and CNS pericyte/VSM
enriched transcripts (brain GFP
+/GFP
+PDGFRbeta
2.2) were
excluded. To identify signaling and metabolic pathways enriched
in specific data sets, Ingenuity Pathway Analysis software core
analysis (Ingenuity systems) was utilized to determine the statistical
significance of enrichment for the pathways within a given data set.
In situ Hybridization
In situ hybridization on P20 fresh frozen mouse brain and liver
sections was performed as described [15] with a few modifications,
omitting the treatment with Proteinase K. The antisense mRNA
probes were generated using the DIG RNA Labeling Kit (Roche
Applied Science, Indianapolis, IN). Ten genes were analyzed by in
situ hybridization on P20 fresh frozen mouse brain and liver
sections: Pecam (SmaI, T7), Cldn5 (XhoI, T3), Apcdd1 (HindIII,
T7), Abcb1a (EcoRV, T7), Slco1c1 (XhoI, T3), Slco1a4 (XhoI, T3),
Slc22a8 (XhoI, T3), Slc7a5 (SalI, T3), Itih5 (SalI, T3), Foxq1
(EcoRV, T7). Apcdd1 cDNA was amplified by RT-PCR using total
RNA isolated from FACS isolated Tie2GFP P60 brain endothelial
cells. The other full length or partial cDNAs were obtained as
mouse ESTs from Open Biosystems (Hunstville Al).
Results
Purification of CNS Vascular Cells from Tie2GFP Mice
To purify cells from the vasculature of different tissues we took
advantage of Tie2GFP transgenic mice available from Jackson
labs. These mice express the green fluoresecent protein (GFP)
under the pan-endothelial Tie2 promotor, and GFP fluorescence
can be visualized in the vasculature of the brain, liver, lung, spleen,
kidney, muscle and other tissue cryosections (Figure 1a)[12]. When
single cell suspensions of adult cerebral cortex were analyzed by
FACS, approximately 5% of the cells were GFP
+, a figure which
matches the proportion of vascular cells in the brain
(Figure 1b)[12]. Using a double FACS procedure to ensure the
highest purity (Figure 1b) we purified three different cell
populations: GFP
2 (parenchymal), GFP
+ (vascular cell), and
GFP
+PDGFRbeta
2 (endothelial cell). For the latter cell population
an anti-PDGFRbeta depletion step was utilized to deplete
pericytes/vascular smooth muscle cells (VSMs) from the sample.
The purity of these cell populations was ascertained by using
Affymetrix microarrays to compare the relative mRNA levels of
specific markers for neurons (synaptotagmin I, synaptophysin,
neuronal enolase), astrocytes (GFAP, Aq4, s100beta), oligoden-
drocyte lineage cells (MBP, MAG, MOBP), microglial cells (cd68,
Ptprc), endothelial cells (Tie2, claudin 5, and Flt1) and pericytes/
VSMs (PDGFRbeta, Abcc9, and Kcnj8) (Figure 1c). As expected,
the neuronal and glial markers were all present in the brain
parenchyma sample and low to absent in the vascular and
endothelial cell samples, indicating these samples did not contain
neural cells. The vascular cell sample contained endothelial and
pericyte/VSM cell markers indicating it was a mixture of these
two cell populations, whereas the endothelial cell sample contained
endothelial cell markers but not pericyte/VSM markers. This
separation allowed us to purify endothelial cells and identify the
endothelial cell transcriptome. Furthermore, comparing the
vascular and endothelial cell data sets we are able to identify
many genes that are highly enriched to pericytes/VSM. A master
data table of all data sets described can be found in Table S1.
In Table S2, we list the enriched CNS endothelial genes,
defined as those GeneChip probe sets significantly enriched
greater than two-fold in the endothelial:parenchymal fractions
BBB Transcriptome
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+ PDGFRbeta
2:GFP
2). We further present a list of the
pericyte/VSM enriched genes, as defined as enriched greater than
two-fold in the Vascular:Endothelial (GFP
+:GFP
+PDGFRbeta
2)
fractions (Table S3). In Table 1 we list the most endothelial and
pericyte enriched probe sets which provide many new endothelial
and pericyte/VSM specific markers within the brain.
Identification of the Blood-Brain Barrier Transcriptome
In order to identify blood-brain barrier enriched transcripts, we
next utilized GeneChip analysis to compare the gene expression in
GFP
+ cells isolated from the brain, liver and lung of adult
Tie2GFP mice. In each case, we used a double FACS purification
procedure in order to isolate GFP
+ cells for maximal purity.
Comparison of the gene profiles of brain and liver, or brain and
lung, revealed that the GFP
+ cell populations in these tissues were
very similar. This is graphically represented by a dot plot, in which
each dot represents a probe set on the Affymetrix GeneChip, and
their position relative to the logarithmic X and Y axes represents
expression levels in the different tissues analyzed (Figure 2a). In
these analyses, the vast majority of genes lie near the diagonal axis,
indicating that their expression levels are not more than two-fold
different between the samples compared. There are, however,
outliers, genes which are expressed at vastly different levels in the
vasculature of the different tissues. These differences were not
identified between two biological replicates of brain GFP
+ cells
(Figure 2a). Furthermore, far greater variation was observed
between the transcriptional profile of brain endothelial cells and
those for neurons and glia (Figure 2a, data for neurons and glia
generated by Cahoy et al 2008). The genes which are expressed at
high levels in the brain vasculature, but low or absent from the
liver and lung, are BBB-enriched genes. For BBB-enriched genes
we identify genes that are enriched in the Brain GFP
+ (vascular)
Figure 1. Purification of endothelial cells from the cerebral cortex of Tie2GFP mice. A) GFP is expressed in the vasculature of Tie2GFP
transgenic mice. GFP (green) can be visualized in a vascular pattern in tissue cryosections of cerebral cortex of an adult Tie2GFP transgenic mouse.
Nuclei were stained with DAPI (blue). Bar, 50 microns. B) FACS purification of GFP
+ cells from the cerebral cortex of Tie2GFP mice. Single cell cortical
suspensions were sorted for GFP fluorescence twice, isolating a GFP
+ cell population that is greater than 99.3% pure. Y-axis represents side scatter co-
efficient, X-axis represents GFP fluorescence, numerical values represent percent of total cells sorted that are within gated region. C) Purity of FACS
sorted cells. GeneChip transcriptional profiling of GFP
2 (parenchyma), GFP
+ (vascular) and GFP
+PDGFRbeta
2 (endothelial) fractions from the cerebral
cortex of Tie2GFP mice. Neuronal, astrocyte, oligodendrocyte, microglial, endothelial and pericyte markers were analyzed to detect the purity of
sample for each FACS sorted sample. The GFP
+ sample contains a mixture of endothelial cells and pericytes, such that an additional PDGFRbeta
negative selection is needed to generate a pure endothelial cell population. Error Bars represent standard error of the mean (SEM).
doi:10.1371/journal.pone.0013741.g001
BBB Transcriptome
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A.Probe Set ID Gene Symbol Brain Endothelial/Parenchyma B.Probe Set ID Gene Symbol Vascular/Endothelial
1421078_at Tcf23 96.1 1423341_at Cspg4 40.9
1438558_x_at Foxq1 71.9 1418773_at Fads3 38.8
1422905_s_at Fmo2 62.1 1455098_a_at Vtn 32.7
1460371_at Hspa12b 62.1 1416286_at Rgs4 27.8
1438227_at She 59.4 1437902_s_at Rarres2 27.1
1436939_at Unc45b 55.4 1459713_s_at Tmem16a 25.8
1419467_at Clec14a 52.4 1425103_at Ace2 24.6
1448117_at Kitl 52.3 1433525_at Ednra 24.3
1447933_at Kif26a 52.0 1426285_at Lama2 22.2
1438325_at Evi1 51.3 1434141_at Gucy1a3 22.0
1422966_a_at Tfrc 48.3 1417439_at Cd248 21.9
1416564_at Sox7 48.0 1448649_at Enpep 21.6
1443832_s_at Sdpr 47.9 1417148_at Pdgfrb 20.1
1438532_at Hmcn1 47.7 1438658_a_at Edg3 20.0
1449184_at Pglyrp1 47.6 1436411_at Atp13a5 20.0
1452352_at Ctla2b 44.8 1438751_at Slc30a10 19.6
1435701_at Cyyr1 44.8 1427221_at Xtrp3s1 18.9
1436419_a_at 1700097N02Rik 44.2 1448421_s_at Aspn 18.2
1449328_at Ly75 42.0 1418142_at Kcnj8 17.7
1428345_at Ppapdc2 42.0 1436203_a_at 1110059G02Rik 16.4
1442698_at --- 41.1 1435751_at Abcc9 16.3
1440926_at Flt1 40.8 1424186_at Ccdc80 15.4
1456061_at Gimap8 40.7 1452474_a_at Art3 15.2
1452013_at Atp10a 40.6 1424902_at Plxdc1 15.0
1418059_at Eltd1 39.6 1424733_at P2ry14 14.6
1438587_at 4933417M04Rik 39.3 1455050_at E130203B14Rik 14.3
1441907_s_at Cd93 38.9 1423477_at Zic1 13.3
1440225_at Gpr116 38.8 1448918_at Slco3a1 13.1
1451500_at Ushbp1 38.7 1448132_at Slc19a1 12.8
1456152_at Paqr5 38.6 1437165_a_at Pcolce 12.8
1447584_s_at Myct1 37.8 1448123_s_at Tgfbi 12.5
1459888_at LOC545261 37.6 1455271_at LOC620695 12.5
1422028_a_at Ets1 37.0 1417011_at Sdc2 12.4
1457867_at Sgpp2 36.9 1434893_at Atp1a2 12.4
1417616_at St6galnac2 36.8 1440879_at Abca9 11.9
1418979_at Akr1c14 36.5 1430700_a_at Pla2g7 11.7
1420459_at Dscr6 36.4 1424099_at 2310016C16Rik 11.7
1438027_at 5830443L24Rik 35.8 1422058_at Nodal 11.7
1457141_at Aqp11 35.7 1417534_at Itgb5 11.6
1416832_at Slc39a8 35.6 1419663_at Ogn 10.1
1429177_x_at Sox17 35.3 1422545_at Tbx2 10.1
1456768_a_at Mmrn2 35.0 1420872_at Gucy1b3 10.0
1444181_at Gimap5 35.0 1435741_at Pde8b 9.9
1419758_at Abcb1a 34.7 1454966_at Itga8 9.8
1426914_at Marveld2 34.5 1449860_at Higd1b 9.4
1432176_a_at Eng 34.3 1416271_at Perp 8.8
1439221_s_at Cd40 34.2 1420688_a_at Sgce 8.7
1448862_at Icam2 33.6 1430136_at Grm3 8.2
BBB Transcriptome
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+ cells and lung GFP
+ cells, and
eliminate any pericyte enriched genes by comparing Brain
GFP
+PDGFRbeta
2 endothelial cells with Brain GFP
+ vascular
cells. Preliminary validation of this data set comes from analyzing
characterized endothelial genes. For instance, known pan-
endothelial genes, including Tie2, PECAM1 and claudin 5, are
expressed at similar levels in all tissue data sets, whereas
established BBB-specific genes glut-1, p-glycoprotein, occludin
and the transferrin receptor, are expressed at significantly higher
levels in the brain vasculature than the liver or lung (Figure 2b). To
further validate our data set we used in situ hybridization to
analyze the expression pattern of the several top brain endothelial
transcripts enriched compared with liver (Itih5, Apcdd1, Abcb1a
and Slco1c1) and lung endothelial cells (Slc22a8, Slc7a5, Slco1a4
and Foxq1) (Figure 3). In each case, we observed expression in
vascular cells in the brain but not liver. Interestingly, the pattern
observed was different between the probe sets tested. For instance,
Itih5 and Foxq1 appeared to be expressed sporadically and
specifically in larger vessels, whereas Apcdd1, Slco1a4 and
Slc22a8 appear to be expressed in smaller vessels. Indeed,
hetereogeneity between the different segments of the CNS
vasculature has been observed[16], and specific transcripts may
be differentially expressed between arteries, arterioles, capillaries,
venules and veins.
From this analysis, we conclude that we have generated a
comprehensive data set representing the blood-brain barrier
transcriptome. In Table 2 we list the most BBB enriched genes:
those with the greatest difference between expression levels in the
brain GFP
+ cells versus liver and lung GFP
+ cells, with
parenchymal and pericyte/VSM transcripts excluded from these
lists. All BBB enriched genes are listed in Table S6. In addition to
identifying BBB enriched transcripts, we can also use this data set
to identify genes which are enriched in the liver and lung
endothelial cells compared with brain endothelial cells (Table S7).
These genes might be important for regulating the permeability of
non-CNS vessels, or imparting specific functions of non-CNS
endothelial cells. In the following sections we present functional
subsets of BBB enriched genes including tight junction proteins,
transporters, signaling molecules and metabolic pathways that
together constitute the blood-brain barrier.
Identification of Novel BBB Enriched Tight Junction
Molecules
Tight junctions (TJs) are crucial components of the blood-brain
barrier [17], but many of the key molecules that constitute these
junctions are not yet known. In Table 3, we list the tight junction
transcripts expressed by brain endothelial cells, and their relative
expression levels in liver and lung endothelial cells. Among the
claudin gene family, claudin 5 and claudin 12 are expressed by
endothelial cells in all tissues, as described in the literature [18,19].
Claudin 1, 3, and 11 have also been suggested to be expressed at
the BBB [11,20,21], however, we did not see a definitive signal for
any of these molecules. We also did not see expression of these
molecules in CNS vessels by mRNA in situ hybridization and
immunofluoresence imaging (data not shown), suggesting that
claudin 5 and 12 are the key claudins expressed at the BBB.
Whereas these endothelial claudins are expressed by endothelial
cells in all tissues analyzed, we found that other tight junction
transmembrane molecules including occludin, marveld2 (tricellu-
lin), and Jam4 are highly enriched in brain endothelial cells. The
specific expression of occludin at the BBB has been well
documented [22], however, the enrichment of Jam4 and marveld2
in CNS endothelial cells is a novel finding. Marveld2 functions to
seal tight junctions at points where three cells meet [23,24]. The
expression of this molecule by brain endothelial cells suggests that
sealing tripartite adhesions may be critical for forming a high
electrical resistance barrier. Endothelial cells of BBB capillaries
form TJs with adjacent endothelial cells, as well as intra-cellular
junctions as they fold over on to themselves forming the vessel
tube. Thus, tripartite adhesions at the BBB could be the interface
between intercellular tight junction strands and intracellular tight
junction strands.
Several intracellular accessory tight junction molecules are also
expressed in all endothelial cells. These include ZO-1, ZO-2,
Mpdz, MPP1, MPP5, MPP6, MPP7, Dlgh1, Dlgh5, Dlgap4, lglh
and Scrib. These proteins may play integral roles in linking the
tight junction to the actin cytoskeleton as well as regulating the
function of the junctions. However, they are expressed by all
endothelial cells, and therefore their presence alone does not
define the BBB. In our data set we have also identified several
interesting cytoplasmic tight junction molecules as being highly
enriched at the BBB, including cingulin-like 1 (jacop) and pard3.
Cingulin-like 1 is also of great interest as it is homologous to
cingulin, which links tight junctions to the actin cytoskeleton [25].
Perhaps the difference between peripheral and CNS endothelial
cells is not the expression of the structural claudins, but in how
claudins are regulated by the cytoskeleton. The pard family
molecules are highly conserved throughout evolution from worms
to flies to mammals and are involved in the formation of
asymmetry in cells during development [26,27]. This is very
interesting as a defining feature of blood-brain barrier forming
endothelial cells is that the tight junctions form highly asymmetric
cells, and that different transporters are localized specifically to the
luminal or abluminal surface [28].
In each case, the BBB enriched TJ molecules identified, whether
occludin, marveld2, jam4, cingulin-like 1, or pard3, all have far
greater expression levels in the brain endothelial cells than liver
endothelial cells, with lung endothelial cells expressing at
intermediate levels. This pattern follows the known level of
permeability of the vessels in each tissue. BBB vessels form a tight
impermeable barrier, liver sinusoidal capillaries are among the
leakiest vessels in the body, whereas lung vessels have an
A.Probe Set ID Gene Symbol Brain Endothelial/Parenchyma B.Probe Set ID Gene Symbol Vascular/Endothelial
1448471_a_at Ctla2a 33.3 1435805_at Lin7a 8.0
1435418_at Slc22a8 33.0 1418157_at Nr2f1 7.6
A) Most enriched CNS endothelial transcripts. List of the 50 most enriched endothelial cell transcripts defined as the greatest ratio of brain endothelial cell (GFP
+
PDGFRbeta
2): brain parenchyma (GFP
2) values analyzed by affymetrix GeneChips.
B) Most enriched CNS pericyte transcripts. List of the 50 most enriched pericyte transcripts defined as the greatest ratio of brain vascular (GFP
+): brain endothelial (GFP
+
PDGFRbeta
2) values analyzed by Affymetrix GeneChips.
doi:10.1371/journal.pone.0013741.t001
Table 1. Cont.
BBB Transcriptome
PLoS ONE | www.plosone.org 5 October 2010 | Volume 5 | Issue 10 | e13741Figure 2. Comparison of transcriptional profiles of brain endothelial cells with liver and lung endothelial cells. A) Affymetrix
GeneChips were utilized to compare gene expression in GFP
+ cells isolated from cerebral cortex, liver and lung of Tie2GFP transgenic mice. The data
is represented as a dot plot on a logarithmic scale, where each point reflects a probe set on the GeneChip. Black dots indicate probe sets identified as
present in both samples, red dots indicate probe sets identified as present in the brain but not peripheral sample, blue dots indicate probe sets
present in the peripheral but not brain sample, and grey dots represent probe sets identified as absent in both samples. Two biological replicates of
the brain GFP
+ samples were compared to identify variation between replicates. In addition, brain GFP
+ cells were compared with profiles generated
for neurons and glia by Cahoy et al (2008). Black diagonal lines represent cutoffs for two-fold, four-fold and eight-fold differences. B) Validation of
transcriptional profiling by comparison of GeneChip expression with known CNS endothelial markers. Expression values are given relative to the brain
GFP
+ sample. Pan endothelial transcripts are expressed in all GFP
+ samples, whereas BBB transcripts were enriched in the Brain GFP
+ sample. Error
bars represent SEM.
doi:10.1371/journal.pone.0013741.g002
BBB Transcriptome
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levels of enriched tight junction molecules follows this pattern
suggests that we may be able to identify novel molecules involved
in barrier function by examining our data set for probe sets whose
expression level increases in the liver GFP
+ to lung GFP
+ to brain
GFP
+ microarray analyses. These quantitative profiles should be
highly useful for identifying candidate genes that may regulate the
differential permeability observed in blood vessels of various tissues
throughout the body. With this in mind, novel molecules that
follow a similar pattern may also be important for BBB formation.
A number of these molecules are known to associate with cellular
junctions in other tissues including Sorbs1, Sorbs2, Enah, Neo1
and Lims2, and thus may be important for BBB formation
[31,32,33,34,35]. In addition we may be able to identify novel
transmembrane molecules involved in structural adhesions.
Intriguing candidates are Itm2a, Apcdd1, Tmeff1, Tmem23,
Ly75, Ly6c, cd34, Pcdh19 and Extl3. Also, several Golgi protein
glycosylation enzymes, including St6galnac2, St8sia4 and st8sia6,
are identified using this analysis, suggesting that processing of
proteins may be important in regulating BBB formation.
Elucidation of the Set of BBB-Enriched Transporters
Another key aspect of the blood-brain barrier is the expression
of transporters by CNS endothelial cells. Whereas many
transporters have already been identified as highly enriched at
the BBB, a genome wide analysis has not been performed before.
In Table 4 we present a list of transporters expressed by the CNS
vasculature. We divide these into four categories: BBB enriched
transporters which are enriched in CNS endothelial cells
compared with peripheral endothelial cells; pan-endothelial
transporters identified in all endothelial cells analyzed; pericyte
enriched transporters (Table 4); and ubiquitous transporters
expressed by all cells analyzed (data not shown). Elucidating the
substrates of these transporters may provide a greater understand-
ing of how endothelial cells participate in the metabolic division of
labor within the CNS. Furthermore, these transporters may be
utilized to target specific molecules for delivery into the brain for
therapeutic purposes.
Identification of Highly BBB-Enriched Signaling and
Metabolic Pathways
The molecular signals that regulate the formation and function
of the BBB remain largely unknown. We therefore took advantage
of Ingenuity Pathway Analysis (IPA) software to analyze the CNS
endothelial enriched transcripts to identify signaling pathways that
are enriched at the BBB or in peripheral endothelial cells
(Table 5a,c). We identified several pathways as being significantly
associated with brain endothelial cells, including the Wnt/beta-
catenin signaling pathway[36]. This pathway has been demon-
strated to be specifically activated in CNS endothelial cells, and is
Figure 3. Selective expression of blood-brain barrier-enriched genes in CNS endothelial cells. Expression of Pecam (A, B), Cldn5 (C, D),
Apcdd1 (E, F), Abcb1a1 (G, H), Slco1c1 (I, J), Slco1a4 (K, L), Slc22a8 (M, N), Slc7a5 (O, P), Itih5 (Q, R) and Foxq1 (S, T) mRNA in the brain and liver of P20
mouse pups. The top four brain endothelial transcripts enriched compared with liver (Itih5, Apcdd1, Abcb1a and Slco1c1) and lung endothelial cells
(Slc22a8, Slc7a5, Slco1a4 and Foxq1) were analyzed, excluding transcripts also expressed in the brain parenchyma (brain GFP
+:brain GFP
2,2), and
those expressed at ,10000 to ensure that the signal would be above the detection limit of the in situ hybridization. Note that Pecam1 and Cldn5
mRNAs are expressed in the endothelial cells in both brain and liver. However, the transcripts for the blood-brain barrier enriched genes are only
present in brain but not liver endothelial cells. Bar, 200 microns.
doi:10.1371/journal.pone.0013741.g003
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A.Probe Set ID Gene Symbol Brain/Liver Brain/Lung B.Probe Set ID Gene Symbol Brain/Liver Brain/Lung
1441946_at Itih5 3124.8 213.3 1418706_at Slc38a3 85.5 821.1
1449070_x_at Apcdd1 3087.4 75.2 1435418_at Slc22a8 774.6 764.3
1419758_at Abcb1a 1848.7 12.9 1418326_at Slc7a5 15.8 734.2
1423343_at Slco1c1 1745.2 310.2 1420405_at Slco1a4 847.4 450.2
1437967_at Titin 948.1 63.9 1423424_at Zic3 438.5 441.2
1448147_at Tnfrsf19 908.6 18.9 1438558_x_at Foxq1 317.0 404.8
1420405_at Slco1a4 847.4 450.2 1423343_at Slco1c1 1745.2 310.2
1447787_x_at Gja7 825.5 3.8 1428223_at Mfsd2 777.8 224.9
1428223_at Mfsd2 777.8 224.9 1441946_at Itih5 3124.8 213.3
1435418_at Slc22a8 774.6 764.3 1426215_at Ddc 142.0 171.7
1418094_s_at Car4 772.1 2.9 1434734_at E130016E03Rik 168.2 167.1
1419700_a_at Prom1 589.5 69.8 1453072_at Gpr160 10.8 165.4
1429154_at Slc35f2 552.5 69.2 1415802_at Slc16a1 59.3 148.3
1447272_s_at Atp10a 527.2 42.8 1442347_at Lrp8 387.2 145.4
1429348_at Sema3c 511.0 1.3 1449184_at Pglyrp1 371.8 116.0
1448557_at 1200015N20Rik 481.7 10.9 1454734_at Lef1 89.5 108.6
1428663_at 5133401H06Rik 472.0 4.8 1436417_at Slc19a3 249.7 105.8
1425779_a_at Tbx1 469.4 25.2 1426399_at Vwa1 202.8 103.8
1423424_at Zic3 438.5 441.2 1418383_at Apcdd1 448.3 95.6
1457867_at Sgpp2 429.8 9.3 1460459_at Paqr5 72.3 80.2
1460465_at A930038C07Rik 419.3 9.8 1439609_at --- 116.6 70.8
1423608_at Itm2a 415.0 25.3 1419700_a_at Prom1 589.5 69.8
1451255_at MGI:1927471 412.6 41.0 1451047_at Itm2a 266.5 69.5
1427157_at E030025D05Rik 390.4 0.8 1429154_at Slc35f2 552.5 69.2
1442347_at Lrp8 387.2 145.4 1437967_at Titin 948.1 63.9
1416301_a_at Ebf1 380.1 11.8 1423858_a_at Hmgcs2 63.9 62.7
1425415_a_at Slc1a1 372.5 12.5 1417061_at Slc40a1 1.1 59.2
1449184_at Pglyrp1 371.8 116.0 1452661_at Tfrc 48.1 55.4
1439505_at Clic5 357.9 0.9 1435123_at C030014M07Rik 52.6 52.2
1426431_at Jag2 325.6 4.4 1424549_at Degs2 156.4 50.0
1438558_x_at Foxq1 317.0 404.8 1456140_at Zic5 61.5 48.7
1448117_at Kitl 261.9 1.2 1426599_a_at Slc2a1 234.7 48.5
1448873_at Ocln 255.5 9.8 1417714_x_at Hba-a1 5.2 47.7
1438452_at Nebl 253.1 4.7 1427931_s_at Pdxk 31.0 43.7
1437360_at Pcdh19 249.8 19.4 1447272_s_at Atp10a 527.2 42.8
1436417_at Slc19a3 249.7 105.8 1451255_at Lsr 412.6 41.0
1454622_at Slc38a5 237.6 13.5 1435026_at Spock2 180.3 37.7
1426599_a_at Slc2a1 234.7 48.5 1456147_at st8sia6 95.7 36.9
1433933_s_at Slco2b1 226.7 18.5 1426082_a_at Slc16a4 94.0 34.0
1418412_at Tpd52l1 216.4 25.6 1417022_at Slc7a3 38.6 33.0
1454795_at Cobll1 216.0 5.9 1435465_at Kbtbd11 129.9 30.5
1426399_at Vwa1 202.8 103.8 1456616_a_at Bsg 24.7 30.1
1452968_at Cthrc1 200.9 7.2 1452202_at Pde2a 0.7 30.1
1459903_at Sema7a 194.3 4.2 1417184_s_at Hbb-b 3.0 29.0
1418979_at 9030611N15Rik 182.3 9.9 1442698_at --- 5.7 28.5
1435026_at Spock2 180.3 37.7 1437268_at Lancl3 53.2 28.0
1434734_at Rad54b 168.2 167.1 1418412_at Tpd52l1 216.4 25.6
1437479_x_at Tbx3 163.6 1.8 1429206_at Rhobtb1 2.7 25.4
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BBB properties including the expression of glut-1 and tight
junction proteins[36,37,38]. The identification of the BBB
inducing Wnt pathway validates this database as a method to
identify pathways that may be important for BBB formation.
The ‘‘LPS/IL-1 mediated inhibition of retinoic x receptor
(RXR) function’’ pathway was enriched with the highest
confidence level in the CNS endothelial cells compared with liver
and lung endothelial cells. The core of this pathway is a
transcriptional cassette activated by the nuclear receptor RXRal-
A.Probe Set ID Gene Symbol Brain/Liver Brain/Lung B.Probe Set ID Gene Symbol Brain/Liver Brain/Lung
1424549_at Degs2 156.4 50.0 1451675_a_at Alas2 6.1 25.4
1426215_at Ddc 142.0 171.7 1451857_a_at 5730593N15Rik 31.2 25.3
The 50 most enriched transcripts in brain GFP
+ cells compared with (A) liver, or (B) lung. Fold-enrichment given as a ratio of brain GFP
+: peripheral GFP
+ microarray
expression values. To highlight BBB enriched transcripts, only probe sets $ two-fold enriched in brain endothelial cells compared with brain parenchyma (GFP
-)a r e
listed, and pericyte genes are excluded.
doi:10.1371/journal.pone.0013741.t002
Table 2. Cont.
Table 3. BBB enriched tight junction molecules.
Probe set Gene Symbol Brain GFP+ Liver GFP+ Lung GFP+
Transmembrane Molecules
1417839_at Cldn5 38079.1 15781.7 25539.9
1433781_a_at Cldn12 1728.6 1554.1 2732.0
1448873_at Ocln 10303.7 40.3 1054.4
1451407_at Jam4 1053.1 21.9 219.6
1436568_at Jam2 11440.3 11372.0 3897.8
1426914_at Marveld2 2877.8 72.7 554.4
Cytoplasmic Adaptors
1450985_a_at Tjp2 9089.6 3809.5 9019.6
1417749_a_at Tjp1 25536.7 14771.9 16378.3
1426691_at Tjap1 509.3 588.0 572.8
1455179_at Mpp7 787.1 195.1 436.3
1434954_at Mpp5 1197.4 1166.8 884.7
1450919_at Mpp1 1438.7 3789.9 1506.7
1435461_at Magi3 3487.4 1785.9 2131.1
1452309_at Cgnl1 8039.7 430.1 1562.4
1415691_at Dlg1 3574.6 2188.6 3425.2
1426465_at Dlgap4 773.3 1219.4 1842.6
1427064_a_at Scrib 551.2 605.5 625.0
1420851_at Pard6g 1176.7 426.6 4731.0
1434775_at Pard3 2325.2 62.8 1465.7
1450937_at Lin7c 2913.0 2055.6 2396.9
1424595_at F11r 4332.0 5220.9 4775.5
1460356_at Esam1 21470.6 16937.8 15387.4
1433956_at Cdh5 2893.8 4790.3 6622.2
1420985_at Ash1l 2011.1 1239.5 2094.6
1426623_a_at Arhgap17 845.4 1530.9 891.0
1452387_a_at Amotl2 2714.8 5359.0 2375.6
1428785_at Amotl1 1989.5 6058.1 2486.1
1454890_at Amot 5943.5 3708.8 835.5
1433676_at Wnk1 15543.9 10052.6 12021.5
Transcripts defined by MGI as tight junction molecules, or related family members, expressed in brain GFP
+ cells with an expression value $500 by Affymetrix GeneChip
analysis. Transcripts highlighted in red are enriched at least 3-fold over liver endothelial cells.
doi:10.1371/journal.pone.0013741.t003
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A.Probe set
ID
Gene
Symbol
Brain
GFP+ Liver GFP+ Lung GFP+ B.Probe set ID Gene Symbol Brain GFP+ Liver GFP+ Lung GFP+
1433933_s_at Slco2b1 7798.5 34.4 420.7 1439368_a_at Slc9a3r2 11220.0 5884.7 9141.2
1423343_at Slco1c1 30482.2 17.5 98.3 1438559_x_at Slc44a2 7412.4 30206.2 17458.8
1420405_at Slco1a4 38443.9 45.4 85.4 1433645_at Slc44a1 8029.7 5969.1 5828.9
1418326_at Slc7a5 13681.2 866.3 18.6 1425364_a_at Slc3a2 18715.9 8790.5 12701.4
1417022_at Slc7a3 2336.3 60.5 70.8 1416832_at Slc39a8 11166.0 16155.8 1380.6
1454991_at Slc7a1 31330.8 696.7 2873.3 1429593_at Slc38a2 3477.9 2701.2 3444.1
1437149_at Slc6a6 21228.3 1608.7 6912.5 1452059_at Slc35f5 1790.0 1341.4 2176.9
1436137_at Slc6a17 243.6 114.6 98.1 1453300_at Slc35d2 1199.2 912.8 421.2
1451486_at Slc46a3 2002.6 343.5 392.6 1433898_at Slc25a30 1114.3 1358.5 556.7
1447227_at Slc40a1 953.7 116.1 22.8 1424735_at Slc25a25 677.4 578.3 766.9
1433751_at Slc39a10 36219.1 1987.1 3932.0 1452717_at Slc25a24 3275.4 2221.4 2520.1
1454622_at Slc38a5 5337.6 22.5 396.4 1450395_at Slc22a5 2034.3 1478.3 1606.7
1418706_at Slc38a3 8758.2 102.4 10.7 1429726_at Slc16a9 6134.7 164.5 4913.5
1429154_at Slc35f2 3223.2 5.8 46.6 1418257_at Slc12a7 1271.8 1519.8 2671.3
1433750_at Slc31a1 3655.1 1091.9 953.6 1451227_a_at Slc10a3 1095.1 1157.3 620.5
1436164_at Slc30a1 23687.8 3827.4 4884.1 1418774_a_at Atp7a 2948.3 2002.4 3669.4
1434773_a_at Slc2a1 41376.6 267.8 1419.6 1442145_at Atp13a3 534.7 250.3 2057.8
1424211_at Slc25a33 936.5 332.8 188.8 1455083_at Atp11c 4660.2 3234.7 3048.5
1453149_at Slc25a32 1131.7 368.3 253.8 1451388_a_at Atp11b 5863.6 1539.2 2495.8
1423109_s_at Slc25a20 1082.6 408.0 515.9 1436544_at Atp10d 3373.8 1319.2 2658.9
1435418_at Slc22a8 9605.2 12.4 12.6
1448299_at Slc1a1 8321.1 61.9 521.2
1436417_at Slc19a3 9686.6 38.8 91.6
1426082_a_at Slc16a4 1724.0 18.3 50.8
1418445_at Slc16a2 3708.5 689.0 232.1
1415802_at Slc16a1 32259.1 544.3 217.5
1447851_x_at Atp10a 16691.2 52.4 676.0
1422906_at Abcg2 24521.4 2038.1 4007.5
1443870_at Abcc4 17102.3 2475.8 872.6
1419759_at Abcb1a 42011.6 129.7 3931.4
C.Probe Set
ID
Gene
Symbol
Brain
Vascular
Brain
Endothelial
Vascular/
Endothelial
1448918_at Slco3a1 474.1 36.3 13.1
1438751_at Slc30a10 824.0 42.1 19.6
1448132_at Slc19a1 1108.0 86.4 12.8
1417622_at Slc12a2 8112.9 2419.8 3.4
1421129_a_at Atp2a3 1456.1 652.0 2.2
1435148_at Atp1b2 1477.6 247.5 6.0
1434893_at Atp1a2 2744.3 221.9 12.4
1436411_at Atp13a5 5209.0 260.3 20.0
1435751_at Abcc9 7314.9 448.6 16.3
1440879_at Abca9 630.6 53.0 11.9
A) BBB enriched transporters. Transporters from the Slc, Slco, ATP and Abc gene families with enriched expression in brain endothelial cells. Transporters identified in
Table S6, all of which have at least a two-fold greater expression value in brain GFP
+ than liver and lung GFP
+ cells, pericyte genes excluded.
B) Endothelial transporters. Transporters expressed in multiple endothelial samples. These transporters were identified as endothelial specific in Table S2, but were not
significantly enriched in brain GFP
+ cells compared to either the liver GFP
+ or lung GFP
+ samples.
C) Pericyte enriched transporters. A list of pericyte enriched transporters from Table S3, defined as those transcripts whose GeneChip expression values have a brain
vascular:endothelial ratio of $2.
doi:10.1371/journal.pone.0013741.t004
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A.BBB enriched signaling pathway P-value B.BBB enriched metabolic pathway P-value
LPS/IL-1 Mediated Inhibition of RXR Function 1.20E-05 Glycosphingolipid Biosynthesis - Neolactoseries 0.004
Serotonin Receptor Signaling 0.001 Glycine, Serine and Threonine Metabolism 0.008
Clathrin-mediated Endocytosis Signaling 0.003 Phenylalanine Metabolism 0.010
Dopamine Receptor Signaling 0.008 Nitrogen Metabolism 0.025
PXR/RXR Activation 0.025 Glycolysis/Gluconeogenesis 0.027
Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes 0.039 Synthesis and Degradation of Ketone Bodies 0.031
Role of Wnt/GSK-3beta Signaling in the Pathogenesis of Influenza 0.039 Histidine Metabolism 0.035
Wnt/beta-catenin Signaling 0.040 Methionine Metabolism 0.035
Type II Diabetes Mellitus Signaling 0.049
C.Peripheral enriched signaling pathway P-value D.Peripheral enriched metabolic athway P-value
Hepatic Fibrosis / Hepatic Stellate Cell Activation 1.60E-07 Sphingolipid Metabolism 0.044
Dendritic Cell Maturation 3.40E-06
Type I Diabetes Mellitus Signaling 1.20E-05
Atherosclerosis Signaling 1.30E-04
Hepatic Cholestasis 3.50E-04
Complement System 3.70E-04
Molecular Mechanisms of Cancer 6.80E-04
Acute Phase Response Signaling 0.001
Caveolar-mediated Endocytosis Signaling 0.001
Role of Osteoblasts, Osteoclasts and Chondrocytes in Arthritis 0.001
Death Receptor Signaling 0.001
Production of NO and Reactive Oxygen Species in Macrophages 0.002
IL-10 Signaling 0.002
TNFR1 Signaling 0.002
Macropinocytosis Signaling 0.002
Leukocyte Extravasation Signaling 0.003
Apoptosis Signaling 0.003
Role of Macrophages, Fibroblasts and Endothelial Cells in Arthritis 0.003
IL-8 Signaling 0.003
NF-kB Signaling 0.003
Antigen Presentation Pathway 0.003
Integrin Signaling 0.004
LPS/IL-1 Mediated Inhibition of RXR Function 0.004
p53 Signaling 0.004
Glioma Invasiveness Signaling 0.004
HER-2 Signaling in Breast Cancer 0.006
VDR/RXR Activation 0.007
Colorectal Cancer Metastasis Signaling 0.008
Graft-versus-Host Disease Signaling 0.009
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis 0.011
IL-9 Signaling 0.011
Virus Entry via Endocytic Pathways 0.012
TWEAK Signaling 0.014
LXR/RXR Activation 0.014
Aryl Hydrocarbon Receptor Signaling 0.015
HMGB1 Signaling 0.017
Airway Pathology in Chronic Obstructive Pulmonary Disease 0.021
Endothelin-1 Signaling 0.023
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initiated by LPS, IL-1 or TNFalpha signals. Many transcripts
whose expression is turned on by RXRalpha are specifically
expressed by CNS endothelial cells. These transcripts include
Oatp2, Mrp4, Mdr1, Aldh, Pltp, Cpt, Hmgcs and Alas1, some of
which are BBB enriched transporters presented in Table 4.
Remarkably, the ‘‘LPS/IL-1 mediated inhibition of RXR
function’’ pathway is also enriched in peripheral endothelial cells
compared with brain endothelial cells. However, the transcripts
enriched in peripheral endothelial cells encode molecules which
inhibit RXRalpha function, including secreted molecules, mem-
brane receptors and cytoplasmic signaling components (Lbp, IL-1,
Cd14, Myd6b, Nfp). This suggests that a fundamental difference
between CNS and peripheral endothelial cells is that RXRalpha
mediated transcription is activated in CNS endothelial cells and
inhibited in peripheral endothelial cells. In addition we have
identified that neurotransmitter signaling, regulation of IL-2, and
other pathways are enriched in brain endothelial cells. These
findings strongly suggest in addition to Wnt signaling, RXRalpha,
and other signaling may impart BBB specific properties to CNS
endothelial cells.
IPA software was also used to identify metabolic pathways
enriched at the BBB or in peripheral endothelial cells (Table 5b,d).
Glycolysis/gluconeogenesis and amino acid metabolism are
enriched at the BBB, suggesting that brain endothelial cells may
be intimately involved in the production of energy metabolites and
amino acids for neurons, a function that has been thought to be
uniquely served by astrocytes.
Prediction of Novel Cell-Cell Signaling Interactions
Between Vascular and Parenchymal Cell Types
From the endothelial and pericyte transcriptome data sets, we
next generated predictions about the molecular nature of the cell-
cell interactions by which endothelial cells and pericytes
communicate. These interactions may be critical for vascular
contraction, remodeling, differentiation, and permeability. In fact
of the top 50 pericyte enriched genes, 40 are predicted by David
Bionformatics or Mouse Genome Informatics (MGI) to encode
transmembrane or secreted proteins, and thus are potentially
important for endothelial-pericyte signaling. Using this analysis we
identified previously known endothelial-pericyte signals, thus
validating this approach. For instance, endothelial secreted
PDGF-BB regulates the proliferation and survival of CNS
pericytes through PDGFRbeta as evidenced by the complete lack
of CNS pericytes in PDGFB or PDGFRbeta deficient mice
[39,40]. In our data set, PDGFB is enriched in endothelial cells
whereas PDGFRbeta is specifically expressed by pericytes. Other
potential endothelial-to-pericyte signals include endothelial-de-
rived Jagged2 or Dll4 activation of pericyte-expressed Notch3, or
endothelial-derived sema3c, sema3g, sema4c and sema7a signaling
to pericyte-expressed plexin B2, Plxdc1 and Plxdc2. Putative
pericyte-to-endothelial signals include pericyte derived TGFbeta
superfamily members bmp5 and nodal, and endothelial cell
expressed activin receptors (Acvr1, Acvrl1) and bmp receptors
(Bmpr2). In addition we identified angiotensin I converting
enzyme 2 (Ace2) as highly expressed by pericytes, and thus likely
to be involved in generating ligands for agtrl1 receptors made by
endothelial cells. These ligand-receptor pairs are thus candidates
to play important roles in brain angiogenesis and BBB develop-
ment.
We further looked for novel vascular-parenchymal cell interac-
tions. Recent work suggests that neural-vascular cellular interac-
tions are important for the development of the nervous system.
Comparing the vascular enriched genes with those expressed by
neurons and glia [14] can lead to the discovery of signaling
pathways important for the development of the CNS. Astrocytes
possess long processes whose endfeet ensheath blood vessels. This
close association has been implicated in regulating angiogenesis,
vascular contraction and blood-brain barrier permeability [41].
C.Peripheral enriched signaling pathway P-value D.Peripheral enriched metabolic athway P-value
Docosahexaenoic Acid (DHA) Signaling 0.023
Cholecystokinin/Gastrin-mediated Signaling 0.024
Induction of Apoptosis by HIV1 0.027
Role of PKR in Interferon Induction and Antiviral Response 0.028
Germ Cell-Sertoli Cell Junction Signaling 0.029
CXCR4 Signaling 0.031
Sphingosine-1-phosphate Signaling 0.032
Retinoic acid Mediated Apoptosis Signaling 0.033
GM-CSF Signaling 0.033
IL-12 Signaling and Production in Macrophages 0.040
Allograft Rejection Signaling 0.040
TNFR2 Signaling 0.046
Autoimmune Thyroid Disease Signaling 0.046
T Helper Cell Differentiation 0.049
Toll-like Receptor Signaling 0.049
A–B) BBB enriched pathways. Ingenuity Pathway Analysis (IPA) software was utilized to identify signaling cascades (A) and metabolic pathways (B) that are significantly
enriched at the BBB. For this analysis BBB enriched transcripts identified in Table S6 were utilized. Pathways in which p-value ,0.05 are displayed.
C–D) Peripheral vascular enriched pathways. IPA software was utilized to identify signaling cascades (C) and metabolic pathways (D) that are significantly enriched in
peripheral vessels compared to brain vessels. For this analysis peripheral enriched transcripts identified in Table S7 were utilized. Pathways in which p-value ,0.05 are
displayed.
doi:10.1371/journal.pone.0013741.t005
Table 5. Cont.
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798 of 2618 are predicted by DAVID bioinformatics to be
membrane or secreted. Of these, many have putative receptors
expressed by endothelial cells. For instance putative astrocytes/
endothelial interactions may be mediated through ApoE/Lrp8;
BMP7/ActrIIa; AGT/Agtrl1; Wnt7a,Wnt7b/Fzd4,Fzd6; ang1/
tie-2, and VEGFa/Flt1, Flt, Kdr. Blood vessels also interact with
neural stem cells in the developing and adult nervous system,
providing a ‘‘vascular niche’’ that maintains stem cells, promotes
their division, and expands neurogenesis [42]. Along these lines,
we identified a high level of expression of potential oligodendro-
cyte precursor cell (OPC) mitogens within endothelial cells
including cxcl12/sdf1, kitl, csf1, and PDGFB, with cognate
receptors being highly expressed by OPCs, respectively cmkor1/
cxcr7, c-kit, csf1r, and PDGFRalpha [43,44,45,46].
Developmental Changes in BBB Gene Expression
In order to understand developmental changes that regulate
angiogenesis and formation of the BBB, we used FACS to purify
and then profile vascular cells (GFP
+) from the cerebral cortex of
Tie2GFP mice of different ages. We compared cells purified
from postnatal (P2–8) mice and adult (p60–70) mice. In Table S4
and Table S5 we list the CNS vascular transcripts significantly
up-regulated and down-regulated during development from
postnatal to adult mice, and in Table 6 we list the signaling
cascades and metabolic pathways identified by IPA that
significantly change during development. Interestingly, Interfer-
on, Prolactin, Growth Hormone, and circadian rhythm signaling
are significantly up-regulated during development suggesting
these pathways may regulate the maturation of the vasculature.
On the other hand, integrin signaling, protein ubiquitination and
hypoxia signaling are all down-regulated during development
suggesting that these pathways may be involved in regulating
angiogenesis.
Discussion
Identification of the Blood-Brain Barrier Transcriptome
In this paper we provide a new resource for understanding gene
expression in the developing and adult CNS vasculature. Previous
gene profiling studies of brain vessels had several limitations
[9,10,11,47] including use of whole vessel fractions, which contain
many different cell types, and the lack of elucidation of peripheral
endothelial profiles for comparison. We have combined FACS
purification with GeneChip analysis to generate a transcriptional
profile of highly purified endothelial cells from the CNS, and
through comparison with liver and lung endothelial cells we have
generated a comprehensive list of transcripts enriched at the BBB.
These transcripts encode tight junction molecules, transporters,
metabolic enzymes, signaling cascades, and proteins of unknown
function, that together form the highly specialized interface
between the blood and the brain. This represents a novel resource
for three reasons. First, we separate CNS endothelial cells from
pericytes/VSM, and thus generate a transcriptional profile of
endothelial cells, the key cells that form the BBB. Second, we
compare brain endothelial cells with peripheral endothelial cells
isolated from the liver and lung, identifying transcripts which are
specific to barrier forming brain endothelial cells. Finally, we have
isolated cells from different ages and thus can identify develop-
mental changes in the BBB. The BBB transcriptome database
should be highly useful for understanding the molecular control of
CNS angiogenesis, BBB permeability, and the cell-cell interactions
in the developing CNS.
Identification of Candidates Transcripts that Control
Vascular Permeability
A hallmark of the BBB is that CNS endothelial cells are held
together by high electrical resistance tight junctions [17,48]. Of the
best characterized tight junction molecules expressed at the BBB,
claudin 5, occludin, ZO-1 and ZO-2, only occludin is specifically
expressed at the blood-brainbarrier and not by non-barrier forming
vessels [18,22]. The fact that occludin deficient mice still form a
functional BBB suggests that the expression of this molecule does
not impart BBB function [49]. It therefore remains a mystery as to
what causes CNS endothelial cells to form these high electrical
resistance tight junctions. In this study we have identified several
tight junction molecules whose expression is enriched at the BBB,
including marveld2, cingulin-like-1, and pard3, that may play a
crucial role in the formation of BBB tight junctions. Our data sets
will also be useful to identify novel molecules not previously known
to be associated with tight junction proteins, which may be
important for BBB integrity. In addition to the highly specialized
vasculature of the blood-brain barrier, there is great heterogeneity
in the structure and function of vessels in all tissues [29,30]. By
analyzing the relative levels of transcripts expressed by the
endothelial cells in different tissues we can generate hypotheses as
to the relevance of different genes for the tissue specific functions of
each vessel, including permeability, leukocyte trafficking, hemosta-
sis, angiogenesis, immunity, and vasomotor tone.
Signaling Pathways Enriched at the BBB
Transplantation experiments have established that the brain
environment signals brain endothelial cells to form the BBB [5],
but the identity of these signals are largely unknown. In particular,
we have identified transcripts from a number of cascades that are
enriched in the vasculature of the CNS including Wnt/beta-
catenin, RXRalpha and other signaling pathways. The identifica-
tion of the Wnt pathway, a known BBB inducing signaling
pathway, validates this database as a method to identify pathways
that may be important for BBB formation.
RXRalpha is a nuclear receptor which activates the transcrip-
tion of a series of molecules. The activity of RXRalpha can be
inhibited by a cytoplasmic kinase cascade initiated by LPS, IL-1 or
TNFalpha signals [50]. Remarkably, genes in the inhibitory
cassette of this pathway, including Lbp, IL-1, Cd14, Myd6b, Nfp
are enriched in peripheral endothelial cells, whereas transcripts
downstream of RXRalpha are enriched in CNS endothelial cells.
Therefore, a fundamental difference between CNS and peripheral
endothelial cells is the expression of the RXRalpha transcriptional
cassette in CNS endothelial cells, and its suppression in peripheral
endothelial cells. RXRalpha is a retinoic acid nuclear receptor
which raises the question: Does retinoic acid (RA) regulate the
BBB? This seems possible as addition of RA to endothelial cell
lines in vitro increases the expression of BBB specific molecules Pgp
and gamma-glutamyl transpeptidase [51,52]. This matches our
result that many of the RXRalpha regulated transcripts are the
BBB enriched transporters, including Oatp2, Mdr1 and Mrp4.
Interestingly, this pathway is inhibited by immune system
modulating cytokines (IL-1) and bacterial LPS. Perhaps infection
and inflammation alter the levels of BBB specific molecules
through regulation of RXRalpha activity.
Targeting Tumor Angiogenesis
In addition to identifying novel barrier forming molecules, our
data also identifies transcripts that may be important for
angiogenesis and/or vascular pathfinding. This is evident as we
have identified integrins and semaphorins, both of which have
BBB Transcriptome
PLoS ONE | www.plosone.org 13 October 2010 | Volume 5 | Issue 10 | e13741Table 6. Developmentally regulated brain endothelial signaling cascades and metabolic pathways.
A.Up-regulated Signaling Pathway P-value C.Down-regulated Signaling Pathway P-value
Interferon Signaling 1.60E-04 Mitochondrial Dysfunction 4.50E-05
Prolactin Signaling 3.90E-04 Airway Pathology in Chronic Obstructive Pulmonary Disease 0.004
Growth Hormone Signaling 0.001 RAN Signaling 0.004
Circadian Rhythm Signaling 0.001 Parkinson’s Signaling 0.006
Synaptic Long Term Potentiation 0.003 Sphingosine-1-phosphate Signaling 0.006
Phospholipase C Signaling 0.005 Molecular Mechanisms of Cancer 0.007
IL-3 Signaling 0.007 Endothelin-1 Signaling 0.007
Cholecystokinin/Gastrin-mediated Signaling 0.007 Integrin Signaling 0.010
Factors Promoting Cardiogenesis in Vertebrates 0.008 Apoptosis Signaling 0.011
Renin-Angiotensin Signaling 0.009 Regulation of eIF4 and p70S6K Signaling 0.017
Molecular Mechanisms of Cancer 0.009 p70S6K Signaling 0.017
NRF2-mediated Oxidative Stress Response 0.010 Cell Cycle Regulation by BTG Family Proteins 0.018
GNRH Signaling 0.011 mTOR Signaling 0.018
JAK/Stat Signaling 0.011 Protein Ubiquitination Pathway 0.019
IGF-1 Signaling 0.012 Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells 0.029
Thrombopoietin Signaling 0.017 Glioma Invasiveness Signaling 0.030
Huntington’s Disease Signaling 0.017 Hypoxia Signaling in the Cardiovascular System 0.032
Hypoxia Signaling in the Cardiovascular System 0.021 IL-8 Signaling 0.032
Role of Macrophages, Fibroblasts and Endothelial Cells in Arthritis 0.025 Production of NO and Reactive Oxygen Species in Macrophages0.035
FLT3 Signaling in Hematopoietic Progenitor Cells 0.026 Death Receptor Signaling 0.042
BMP signaling pathway 0.026 Induction of Apoptosis by HIV1 0.045
EGF Signaling 0.029 Fcc Receptor-mediated Phagocytosis in Macrophages 0.049
p53 Signaling 0.030 HMGB1 Signaling 0.049
Glioblastoma Multiforme Signaling 0.034
Cardiomyocyte Differentiation via BMP Receptors 0.035
Endoplasmic Reticulum Stress Pathway 0.035
VDR/RXR Activation 0.036
Corticotropin Releasing Hormone Signaling 0.036
Retinoic acid Mediated Apoptosis Signaling 0.039
Human Embryonic Stem Cell Pluripotency 0.041
p38 MAPK Signaling 0.041
Prostate Cancer Signaling 0.044
Ephrin Receptor Signaling 0.046
Melanocyte Development and Pigmentation Signaling 0.046
Aryl Hydrocarbon Receptor Signaling 0.046
Oncostatin M Signaling 0.048
CNTF Signaling 0.048
Activation of IRF by Cytosolic Pattern Recognition Receptors 0.048
FGF Signaling 0.049
B.Up-regulated Metabolic Pathway P-value D.Down-regulated Metabolic Pathway P-value
Riboflavin Metabolism 0.022 Oxidative Phosphorylation 0.001
Pentose Phosphate Pathway 0.001
Methane Metabolism 0.004
Phenylalanine Metabolism 0.004
Purine Metabolism 0.010
Lysine Degradation 0.020
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Identifying such molecules may be important for developing
treatments for brain tumors, as formation of new vessels is a
critical step in tumor progression. Disruption of tumor angiogen-
esis, without harming mature vessels, is a powerful technique for
limiting tumor growth [56,57]. To accomplish this, it is key to
identify potential targets found on angiogenic vessels, that are
absent from mature vessels or parenchymal tissue. In this resource
we have identified transcripts whose expression level changes from
developmental stages where robust angiogenesis is occurring, to
adult animals where angiogenesis is largely completed. Potential
targets include prion protein doublet (prnd), madcam1, tachykinin
receptor 3, Slc7a8, and Cxcr4. Each of these transcripts is
enriched in postnatal brain endothelial cells as compared with
adult brain, liver and lung endothelial cells, and adult CNS
parenchyma.
In summary, we have generated a comprehensive data set
describing the transcriptome of the BBB. This will provide a
valuable resource for understanding the development and function
of this crucial barrier, as well as its role modulating CNS function.
Supporting Information
Table S1 Complete Excel spreadsheet. The Excel spreadsheet
containing the comprehensive list of probe sets from the mouse
430-2 GeneChip, with expression values for adult brain GFP
2,
adult brain GFP
+, adult brain GFP
+PDGFRbeta
2, liver GFP
+,
lung GFP
+, and postnatal brain GFP
+ samples. Each expression
value is the average of at least three biological replicates.
Found at: doi:10.1371/journal.pone.0013741.s001 (9.96 MB
XLS)
Table S2 Endothelial specific genes. A data set containing probe
sets from the mouse 430–2 GeneChip statistically enriched in CNS
endothelial cells compared with CNS parenchyma as identified by
probe sets with GFP
+PDGFRbeta
2:GFP
2 .2 with expression
value in GFP
+PDGFRbeta
2.200. SAM algorithms were utilized
to identify significance.
Found at: doi:10.1371/journal.pone.0013741.s002 (0.87 MB
XLS)
Table S3 Pericyte specific genes. A data set containing probe
sets from the mouse 430–2 GeneChip statistically enriched in CNS
pericytes compared with CNS endothelial cells as identified by
probe sets with GFP
+:GFP
+PDGFRbeta
2.2 with expression
value in GFP
+.200. SAM algorithms were utilized to identify
significance.
Found at: doi:10.1371/journal.pone.0013741.s003 (0.10 MB
XLS)
Table S4 Developmentally up-regulated CNS vascular genes. A
data set containing probe sets from the mouse 430–2 GeneChip
statistically up-regulated in CNS vessels during development as
identified by probe sets with adult GFP
+:postnatal.2 with
expression value in adult GFP
+.200. Pericyte genes were
eliminated from this dataset. SAM algorithms were utilized to
identify significance.
Found at: doi:10.1371/journal.pone.0013741.s004 (0.43 MB
XLS)
Table S5 Developmentally down-regulated CNS vascular genes.
A data set containing probe sets from the mouse 430–2 GeneChip
statistically down-regulated in CNS vessels during development as
identified by probe sets with adult GFP
+:postnatal,2 with
expression value in postnatal GFP
+.200. Pericyte genes were
eliminated from this dataset. SAM algorithms were utilized to
identify significance.
Found at: doi:10.1371/journal.pone.0013741.s005 (0.40 MB
XLS)
Table S6 BBB enriched genes. A data set containing probe sets
from the mouse 430–2 GeneChip statistically enriched in CNS
endothelial cells compared with those from the CNS parenchyma
as identified by probe sets with BrainGFP
+:LiverGFP
+.2 and
BrainGFP
+:LungGFP
+.2 with expression value in BrainGFP
+.
200. Additionally separate work sheets are presented for data sets
containing BrainGFP
+:LiverGFP
+.2 with expression value in
BrainGFP
+.200, and BrainGFP
+:LungGFP
+.2 with expression
value in BrainGFP
+.200. Pericyte genes were eliminated from
each dataset. SAM algorithms were utilized to identify signifi-
cance.
Found at: doi:10.1371/journal.pone.0013741.s006 (1.01 MB
XLS)
Table S7 Peripheral endothelial enriched genes. A data set
containing probe sets from the mouse 430–2 GeneChip statisti-
cally enriched in peripheral endothelial cells compared with those
from the CNS as identified by probe sets with LiverGFP
+:
BrainGFP
+ .2 and LungGFP
+:BrainGFP
+ .2 with expression
value in LiverGFP
+.200 and LungGFP
+.200. SAM algorithms
were utilized to identify significance.
Found at: doi:10.1371/journal.pone.0013741.s007 (0.28 MB
XLS)
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